Skip to main content
. 2021 Jun 4;394(8):1737–1755. doi: 10.1007/s00210-021-02096-0

Fig. 2.

Fig. 2

In vitro characterization of rivastigmine PLGA nanoparticles. (a) Zeta potential; (b) particle size measurements; (c) SEM and (d) TEM images of rivastigmine loaded nanoparticles; (e) typical HPLC chromatogram of rivastigmine in nanoparticles formulation; (f) in vitro release profile